Rhenman & Partners Asset Management Ab Royalty Pharma PLC Transaction History
Rhenman & Partners Asset Management Ab
- $1.2 Billion
- Q3 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 613,500 shares of RPRX stock, worth $18.9 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
613,500
Previous 544,697
12.63%
Holding current value
$18.9 Million
Previous $14.4 Million
20.83%
% of portfolio
1.45%
Previous 1.42%
Shares
12 transactions
Others Institutions Holding RPRX
# of Institutions
411Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.26 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$708 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$496 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$372 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...